This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,968.88, is a Firm Fixed Price Delivery Order for the medical product GEMTESA 75 MG TABLET 90S. The contract has a period of performance through December 10, 2024 and was awarded on December 9, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any set-aside requirements for this award. The contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/16/25, 12:45 AM